CompletedNCT05685732
Azstarys effectiveness and safety in children with ADHD
About this title
Read the official source — NCT05685732Medication studyAges 4–12United States
Understand this study
Who was this study for?
Listed age limits: 4 years to 12 years.
- Listed locations
- Little Rock and 19 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: March 22, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 246
- Sponsor
- Corium, Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 4 Years to 12 Years
- Official registry ID
- NCT05685732
- Official title
Show the full official title
A Multicenter, Dose-Optimized, Randomized, Double Blind, Efficacy and Safety Study With Azstarys® in Children 4 to 12 Years of Age With Attention Deficit/Hyperactivity Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedLittle Rock · Anaheim · Centennial
17 more locations
- Jacksonville
- Lakeland
- Maitland
- Miami Springs
- Orlando
- Atlanta
- Decatur
- Savannah
- New Orleans
- Saint Charles
- Missoula
- Lincoln
- Las Vegas
- Memphis
- Bellaire
- Plano
- San Antonio
Questions about this study
Who is behind this study?
The study sponsor is Corium, Inc.
Did this study involve medication?
Yes. The study involved medication, including Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH).
Who was this study for?
Listed age limits: 4 years to 12 years.
